Clinical trial
Phase 2 Study - Erdosteine in Patients With CB/COPD
NCT00338507 · Adams Respiratory Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00338507 |
|---|---|
| Title | Phase 2 Study - Erdosteine in Patients With CB/COPD |
| Official title | A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Dose_Ranging Study of Erdosteine for the Treatment of Stable Chronic Bronchitis Associated With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Adams Respiratory Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Bronchitis, Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Erdosteine |
| Enrollment | 400 |
| Start date | Mar 1, 2006 |
| First posted | Jun 20, 2006 |
| Last update posted | Dec 6, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: